This can be explained by the fact that early initiate ART can improve health status, delay the early onset of co-morbidity, decrease the adjusted mortality rates compared to those who defer ART until reaching CD4 <500 cells/μL [31], and therefore improve mental health and quality of life of HIV/AIDS patients [32]. Here, CD4 is linked to AIDS.